Glaucoma 2020

Novel Approaches for Ophthalmic Drug Delivery

Submit Abstract Register Now

Visual medical speciality in Pharmacology and medicine is the principle multidisciplinary supplying crucial and basic clinical research about biopharmaceuticals and different techniques which can possibly treat, anticipate, and/or analyze visual maladies and disarranges. Some of the breakthrough in ophthalmic research and advance drug delivery system can be Punctal Plugs, Ocular Therapeutics, Mati therapeutics (QLT) and gel-forming drops to widen the therapeutic effect of a specific drug. Topical combination of corticosteroid & anti-infective agents, Drugs used in the treatment of allergic conjunctivitis, Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs) and Retinoblastoma chemotherapy are few developed formulations to treat ophthalmic diseases. The use of drug-loaded contact lenses and ocular inserts allows drugs to be better placed where they are needed for more direct delivery. Developments in ocular implants provides a method to beat the physical barriers that conventionally prevented efficacious treatment. Implant technologies area are beneath development permitting everlasting drug delivery from one procedure, these devices permitted posterior chamber diseases to be completely treated. Future developments might come with artificial corneas to abolish the necessity for donor tissue and occurrence of implantable drug depots remaining the patient's duration of life. Drugs, that are used, are the types of Phenylephrine, Cyclopentolate, Antihistamines and Decongestants.

Allergan, Pfizer, Bausch + Lomb, Merck & Co. and Regeneron like companies are vigorously involving in ophthalmic research and drug development. According to Visiongain (Ophthalmic Drugs: World Market Prospects - 2013-2023; October 2013), the worldwide ophthalmic market was $17.5 billion in 2011 and is expected to grow to $34.7 billion by 2023, representing a 5.9% compounded annual growth rate.